ROBERT S. LASNIK, District Judge.
Defendant Cygnus Medical LLC ("Cygnus") is the owner of United States Patent No. 7,648,023 ("the patent" or "the `023 patent") which relates to a cleaning kit for an endoscope that can be used immediately after a procedure to clear debris from the channel and insertion tube of the endoscope before a more thorough cleaning is conducted. Cygnus claims that Plaintiff Medtrica Solutions Ltd. and third-party defendant STERIS Corp. (collectively "Medtrica") infringed and continue to infringe the `023 patent. The parties disagree about the interpretation of five terms used in the claims of the patent.
The claims of the patent define the invention and the scope of the patentee's right to exclude.
The
When interpreting claim terms, district courts may also "rely on extrinsic evidence, which `consists of all evidence external to the patent and prosecution history, including expert and inventor testimony, dictionaries, and learned treatises.'"
Having reviewed the memoranda and exhibits submitted by the parties and having heard the arguments of counsel on June 20, 2013, the Court finds as follows:
Many of the disputed terms are used throughout the patent in various forms: "weakened line," for example, also appears as "weakness line" and "line of weakness." Because any construction ascribed to the disputed terms will have equal effect throughout the various claims at issue, the Court starts with claim 1 of the '023 patent, reproduced here with four of the disputed terms in italics:
The parties agree that the term "weakened line" is in dispute. Dkt. # 92 at 2. Cygnus contends that "weakened line" should be afforded its plain and ordinary meaning, which it asserts is "a line that creates a weakness to ease opening of the pouch — it simply allows the top portion to be opened so that a user can easily access the liquid detergent." Dkt. # 94 at 6.
Cygnus's proposed construction, however, is at odds with the claim construction mandated by the claims themselves and the prosecution history. This proposed construction would remove the word "weakened" from its proper context describing the word "line" and create the presence of a general "weakness" even though this undefined weakness is not supported by the claims.
In addition, the word "in" following "weakened line" implies a physical relationship between the line and the front and back sidewall panels. `023 patent, col. 7, ll. 14-15. This context suggests that the line is not just hypothetical, but physically noticeable to the user. The prosecution history supports this interpretation. In Response to an Official Action by the USPTO, Cygnus added "at least one weakened line" to claim 1 of the `023 patent. Dkt. # 96-6 at 3. In its response to the USPTO's rejection for obviousness, Cygnus explained that "the at least one weakened line" "is an important aspect of the present invention because it provides a user with a quick and convenient access [to] the detergent in order to clean the endoscope."
Cygnus appears to suggests that the disputed term is a means-plus-function limitation under 35 U.S.C. § 112(f). Dkt. # 101 at 4. If the term is a means-plusfunction limitation, "the claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. 35 U.S.C. § 112(f). Dkt. # 101 at 4. Cygnus's proposed interpretation, again, is inconsistent with the actual language of the claim. The term, considered in context, describes a physical structure for the front and back sidewall panels. Therefore, the Court finds that meansplus-function claiming does not apply.
Having declined to adopt Cygnus's proposed construction of "weakened line," the Court now turns to Medtrica's proposed construction. Medtrica argues that "weakened line" should be construed to mean "at least one long, thin area or mark, on each of the front and back sidewall panels, that is discernibly less strong than the remainder of the sidewall panels." Dkt. # 95 at 7.
Cygnus argues that Medtrica relies too heavily on one embodiment in which the "weakened line" may be created by perforating or scoring the sidewall panels. Dkt. # 95 at 12-13 (citing `023 patent, col. 5, ll. 54-63). Cygnus contends that Medtrica seeks to limit the scope inappropriately based on a single embodiment. Dkt. # 101 at 3-4. Rather, Cygnus argues, the term should not be construed to prohibit another embodiment in which "[o]ne or both ends of the weakness line preferably terminates with a notch (not shown), which provides a stress concentration and aids in starting a tear along weakness line when pouch is opened by a consumer." Dkt. # 101 at 3-4.
The Court finds that construing the term to include the physical nature of the term does not improperly impose any limitations based on a particular embodiment. While the specification implies that the weakened line may be formed by perforating or scoring the sidewalls and end with a notch, `023 patent, col. 5, ll. 54-67, the weakened line may still terminate in one or more notches. The preferred embodiment may have at least one notch, but the specification and the claims make clear that unlike the "weakened line," a notch is not required. The claims themselves provide the structural nature of the "weakened line" and Cygnus confirmed that the "weakened line" is a requirement of the invention when it responded to the USPTO's action.
Although Medtrica's construction does not improperly limit the claim based on a single embodiment as Cygnus contends, it does provide limitations not supported by the language of the claims or the specification. Medtrica's construction improperly inserts "long" and "thin," two adjectives that are not suggested by the specification. Medtrica fails to explain why it chose to include these words in its construction and the Court declines to limit the claim using those words. The Court also finds that Medtrica's proposed construction attempts to re-write more of the claim than the disputed term. Dkt. # 95 at 10 ("
The patent documents are unambiguous and thus, "weakened line" may be construed based on the intrinsic evidence alone.
The parties disagree whether the Court should construe the term "adapted to absorb." Medtrica argues that the term should be construed as "capable of absorbing, but not necessarily containing detergent." Dkt. # 95 at 21. Medtrica relies on part of the claim that states a pad may be included inside the pouch or attached to the outside of the pouch for its proposition that the pad need not actually contain detergent. Dkt. # 95 at 22. That claim language, however, describes the placement of the pad in relation to the pouch, not the composition of the pad. `023 patent, col. 7, ll. 7-10. The Court will not impose a limitation regarding the characteristics of the pad where the claims themselves do not support that limitation. The Court construes "adapted to absorb" as "capable of absorbing."
Medtrica argues that "in the front and back sidewall panels" should be construed as "in both the front and back sidewall panels, but not in the side seals." Dkt. # 95 at 19-21. Cygnus contends that the term should be given its plain and ordinary meaning and no further construction is necessary. Dkt. # 101 at 6. The Court will not incorporate into the term limitations regarding side seals. The word "both" is unnecessary as the term already implies that the weakened line must be on both sidewall panels. The disputed term is not technical or ambiguous. Thus, the Court agrees with Cygnus that "in the front and back sidewall panels" does not need to be construed.
Like the previous term, the parties disagree about whether this claim needs to be construed. Dkt. # 95 at 3; Dkt. # 101 at 6. Medtrica seeks to construe this term by adding words that describe the method by which the pouch stands upright. Medtrica proposes that "capable of standing upright" means "able to stand upright with or without external force." Dkt. # 95 at 23. However, neither the claims nor the specification disclose how the pouch stands. At most, the intrinsic evidence describes a preferred embodiment in which the bottom gusset panel is attached sidewalls in a way that "allows the pouch to stand upright without being supported." `023 patent, col. 4, ll. 57-63. "With or without external force" does not clarify the claims. Furthermore, this term is not highly technical in nature or vague. Further construction would not help the jury. Thus, the Court finds that "capable of standing upright" does not need to be construed.
The parties disagree about whether the Court should construe "adapted to allow access" in claim 10 of the `023 patent. On one hand, Medtrica contends that the term should be construed as "whereby the pouch is torn along the weakened line." Dkt. # 95 at 24-26. Cygnus, on the other hand, contends that the term, like the previous three, should be given its plain and ordinary meaning and no construction is necessary. Dkt. # 101 at 6. The Court agrees with Cygnus.
Medtrica's proposed construction runs afoul of the doctrine of claim differentiation. Claim 10 states only that the "pouch includes at least one weakened line in the front and back sidewall panels adapted to allow access to [the] detergent." `023 patent, col. 7, ll. 59-61. Claim 11, which depends from claim 10, adds a limitation that "the top seal is adapted to be torn away before cleaning of the endoscope."
Because claim 10 does not recite any specific means for accessing the detergent inside the pouch, the Court declines to construe "adapted to allow access" to mean "whereby the pouch is torn along the weakened line." The term is not technical and does not require further construction by the Court in light of its context.
It is so ORDERED.